Skip to content

Adherence in Cape Town poor just as good as US and Europe

Novel antibody enters trials as HIV treatment

Discredited hydroxyurea back on the agenda

Preventative vaccine study starts in Australia

Long-anticipated therapeutic HIV vaccines show early promise

Monitoring ARV treatment

BHIVA issues draft 2003 treatment guidelines

HIV experts question observed therapy in poor nations

Complementary therapies used by over 50% of HIV patients but many do not discuss use with doctors